Described herein are pharmaceutical packaging systems which protect against oxidative degradation of morphine, hydromorphone, promethazine as well as other oxygen-delicate prescription drugs, this sort of methods which includes a syringe with an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with extremely low perm